Decoy Therapeutics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Decoy Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- Decoy Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-06-30 was $63.10K.
- Decoy Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-03-31 was $54.91K.
- Decoy Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $118.01K, a 4383.66% increase from fiscal 2017.
- Decoy Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $2.63K, a 88.09% decline from fiscal 2016.
- Decoy Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $22.10K, a 94.59% decline from fiscal 2015.
- Decoy Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2015 was $408.32K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $118.01K 10-K · filed 2019-03-06 | |
| 2018-06-30 | $63.10K 10-Q · filed 2019-07-17 | |
| 2018-03-31 | $54.91K 10-Q · filed 2019-07-17 | |
| 2017-12-31 | $2.63K 10-K · filed 2019-03-06 | |
| 2016-12-31 | $22.10K 10-K · filed 2019-03-06 | |
| 2015-12-31 | $408.32K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |